Health insurance allowance to be possible for antibiotic Tygacil

Published: 2008-10-17 06:49:00

Updated: 2008-10-17 06:49:00

Wyeth Korea says patients will be allowed to receive insurance reimbursement over its antibiotic Tygacil as a result of the recent pricing negotiation with the National Health Insurance Corporation.

Tigecycline is a glycylcycline antibiotic developed and marketed by Wyeth under the brand name ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK